We have expertise in developing various dosage forms such as: oral solids, liquids, injectables, and topicals etc. Dharma Labs could be a partner of choice for late stage compounds, matured products and novel branded (Specialty) prescription pharmaceutical products.Our development programs include ANDA, Paragraph IV, NDA submissions utilizing the FDA 505(b)(2) pathway that involve novel formulations, alternative delivery forms and combinations of prescription products that have already received U.S. regulatory approval. This development approach significantly reduces development time, cost and risk. We have decades of firsthand experience in market research, clinical development, regulatory, formulation development and technology transfer.